Excessive tearing; a paradoxical ocular manifestation of Parkinson’s disease
Objective: To demonstrate a case report of excessive tearing in Parkinson’s disease patient Background: Dry eye is the common ocular manifestations in PD patients. The…Eye closure during tasks in blepharospasm (BSP)
Objective: To quantify modulation of eye closure rates during activities of daily living in individuals with BSP and asymptomatic individuals with and without family history…Serial Cases: Blepharospasm With Oromandibular Dystonia (Meige Syndrome) (Rare Case)
Objective: Meige syndrome is a type of cranial dystonia characterized by blepharospasm and oromandibular dystonia and can be associated with complex movements of the muscles…The main reasons for essential blepharospasm botulinum neurotoxin (BoNT) treatment discontinuation in Latvian population.
Objective: To investigate the effectiveness of BoNT treatment in patients with essential blepharospasm and determine the most common reasons for discontinuation of the treatment. Background: Essential…Does Microneedle Use for Facial Injection of Botulinum Toxin Reduce Pain? A Systematic Literature Review
Objective: To perform a systematic review to identify relevant literature on pain outcomes after injecting BTX with a microneedle for various facial conditions and to…Gait Dysfunction in Blepharospasm
Objective: Characterizing gait in blepharospasm patients. Background: Blepharospasm ranges from frequent blinking to forced eye closure potentially causing functional blindness that can impair walking. Gait…Blepharospasm – a network disorder
Objective: We present a case with apraxia of eyelid opening, orbicularis oculi spasms, increased blinking, which falls within the new paradigm that defines blepharospasm, that…Cost-Utility Analysis of Flexible Intervals with IncobotulinumtoxinA Versus Fixed Dosing with OnabotulinumtoxinA in the Management of Cervical Dystonia and Blepharospasm in Major Canadian Markets
Objective: The aim was to carry out a cost-utility analysis for IncobotulinumtoxinA (INCO) administered with flexible treatment intervals compared to onabotulinumtoxinA (ONA) administered with fixed…Long-term safety and efficacy of incobotulinumtoxinA for the treatment of blepharospasm in botulinum toxin-naïve subjects: results of a Phase III study
Objective: To assess the safety and efficacy of incobotulinumtoxinA for benign essential blepharospasm (BEB) in toxin-naïve subjects. Background: IncobotulinumtoxinA is efficacious for BEB. This was…Duration of Effect of IncobotulinumtoxinA for the Treatment of Blepharospasm in Botulinum Toxin-naïve Subjects: Results from a Phase III Study
Objective: The efficacy of incobotulinumtoxinA, a botulinum neurotoxin type A free from complexing proteins, was investigated in a randomized, placebo-controlled, prospective, Phase III study in…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.